These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12423668)

  • 21. Nociceptin/orphanin FQ into the rat periaqueductal gray decreases the withdrawal latency to heat and loading, an effect reversed by (Nphe(1))nociceptin(1-13)NH(2).
    Bytner B; Huang YH; Yu LC; Lundeberg T; Nylander I; Rosen A
    Brain Res; 2001 Dec; 922(1):118-24. PubMed ID: 11730709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
    Peng YL; Chang M; Dong SL; Li W; Han RW; Fu GX; Chen Q; Wang R
    Regul Pept; 2006 May; 134(2-3):75-81. PubMed ID: 16516988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nociceptin system and hippocampal cognition in mice: a pharmacological and genetic analysis.
    Kuzmin A; Madjid N; Johansson B; Terenius L; Ogren SO
    Brain Res; 2009 Dec; 1305 Suppl():S7-19. PubMed ID: 19782658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nociceptin and nocistatin on antidromic vasodilatation in hairless skin of the rat hindlimb in vivo.
    Häbler H; Timmermann L; Stegmann J; Jänig W
    Br J Pharmacol; 1999 Aug; 127(7):1719-27. PubMed ID: 10455331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
    Chiou LC; Liao YY; Fan PC; Kuo PH; Wang CH; Riemer C; Prinssen EP
    Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
    Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nocistatin and nociceptin given centrally induce opioid-mediated gastric mucosal protection.
    Zádori ZS; Shujaa N; Köles L; Király KP; Tekes K; Gyires K
    Peptides; 2008 Dec; 29(12):2257-65. PubMed ID: 18930088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-Benzyl-N-[3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl]pyrrolidine-2-carboxamide (Compound 24) antagonizes NOP receptor-mediated potassium channel activation in rat periaqueductal gray slices.
    Liao YY; Trapella C; Chiou LC
    Eur J Pharmacol; 2009 Mar; 606(1-3):84-9. PubMed ID: 19374842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proinflammatory and vasodilator effects of nociceptin/orphanin FQ in the rat mesenteric microcirculation are mediated by histamine.
    Brookes ZL; Stedman EN; Guerrini R; Lawton BK; Calo G; Lambert DG
    Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H2977-85. PubMed ID: 17766480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radioligand and GTPgamma(35)S binding studies.
    McDonald J; Calo G; Guerrini R; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):183-7. PubMed ID: 12595960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of co-administration of intrathecal nociceptin/orphanin FQ and opioid antagonists on formalin-induced pain in rats.
    Lee H
    Yonsei Med J; 2013 May; 54(3):763-71. PubMed ID: 23549827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
    Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G
    Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats.
    Ciccocioppo R; Economidou D; Fedeli A; Massi M
    Physiol Behav; 2003 Jun; 79(1):121-8. PubMed ID: 12818717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex.
    Mela F; Marti M; Ulazzi L; Vaccari E; Zucchini S; Trapella C; Salvadori S; Beani L; Bianchi C; Morari M
    Eur J Neurosci; 2004 Mar; 19(5):1317-24. PubMed ID: 15016089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.
    Kapusta DR; Chang JK; Kenigs VA
    J Pharmacol Exp Ther; 1999 Apr; 289(1):173-80. PubMed ID: 10087001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of synaptic transmission by nociceptin/orphanin FQ and nocistatin in the spinal cord dorsal horn of mutant mice lacking the nociceptin/orphanin FQ receptor.
    Ahmadi S; Kotalla C; Gühring H; Takeshima H; Pahl A; Zeilhofer HU
    Mol Pharmacol; 2001 Mar; 59(3):612-8. PubMed ID: 11179457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia.
    Scoto GM; Aricò G; Ronsisvalle S; Parenti C
    Peptides; 2007 Jul; 28(7):1441-6. PubMed ID: 17628212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection.
    Le Cudennec C; Naudin B; Do Rego JC; Costentin J
    Life Sci; 2002 Nov; 72(2):163-71. PubMed ID: 12417250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central nociceptin/orphanin FQ system elevates food consumption by both increasing energy intake and reducing aversive responsiveness.
    Olszewski PK; Grace MK; Fard SS; Le Grevès M; Klockars A; Massi M; Schiöth HB; Levine AS
    Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R655-63. PubMed ID: 20427724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ZP120 causes relaxation by pre-junctional inhibition of noradrenergic neurotransmission in rat mesenteric resistance arteries.
    Simonsen U; Laursen BE; Petersen JS
    Br J Pharmacol; 2008 Mar; 153(6):1185-94. PubMed ID: 18193068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.